In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18.
Appalaraju B, Baveja S, Baliga S, Shenoy S, Bhardwaj R, Kongre V, Dattatraya GS, Dhole T, Verma B, Mukherjee DN, Gupta S, Shanmugam P, Iravane J, Mishra SR, Barman P, Chopra S, Hariharan M, Surpam R, Pratap R, Joshi P, Khande H, Mane A, Jain R, Bhagwat S.
Appalaraju B, et al. Among authors: shenoy s.
J Antimicrob Chemother. 2020 Mar 1;75(3):600-608. doi: 10.1093/jac/dkz493.
J Antimicrob Chemother. 2020.
PMID: 31840170